Edition:
United States

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

9.72USD
2:19pm EST
Change (% chg)

$-0.33 (-3.28%)
Prev Close
$10.05
Open
$10.20
Day's High
$10.20
Day's Low
$9.62
Volume
199,022
Avg. Vol
435,946
52-wk High
$19.80
52-wk Low
$7.85

Chart for

About

Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program... (more)

Overall

Beta: 4.58
Market Cap(Mil.): $552.43
Shares Outstanding(Mil.): 70.37
Dividend: --
Yield (%): --

Financials

  IOVA.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -2.11 -- --
ROI: -49.36 0.29 15.02
ROE: -80.46 0.94 16.60

Earnings vs. Estimates